Aquestive Therapeutics Inc (AQST)
3.10
-0.18
(-5.49%)
USD |
NASDAQ |
May 17, 16:00
3.10
0.00 (0.00%)
After-Hours: 20:00
Aquestive Therapeutics Free Cash Flow (Quarterly): -10.41M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -10.41M |
| December 31, 2023 | -4.958M |
| September 30, 2023 | -2.498M |
| June 30, 2023 | -8.733M |
| March 31, 2023 | 8.814M |
| December 31, 2022 | 8.39M |
| September 30, 2022 | 1.092M |
| June 30, 2022 | -7.239M |
| March 31, 2022 | -14.59M |
| December 31, 2021 | -8.594M |
| September 30, 2021 | -9.148M |
| June 30, 2021 | -1.95M |
| March 31, 2021 | -14.20M |
| December 31, 2020 | -13.75M |
| September 30, 2020 | -8.351M |
| Date | Value |
|---|---|
| June 30, 2020 | -10.11M |
| March 31, 2020 | -13.77M |
| December 31, 2019 | -10.66M |
| September 30, 2019 | -14.88M |
| June 30, 2019 | -17.28M |
| March 31, 2019 | -18.06M |
| December 31, 2018 | -3.302M |
| September 30, 2018 | -11.92M |
| June 30, 2018 | -0.116M |
| March 31, 2018 | 0.526M |
| December 31, 2017 | -7.497M |
| September 30, 2017 | 15.19M |
| June 30, 2017 | -7.192M |
| March 31, 2017 | 3.251M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-17.28M
Minimum
Jun 2019
8.814M
Maximum
Mar 2023
-7.641M
Average
-8.940M
Median
Free Cash Flow (Quarterly) Benchmarks
| Lifecore Biomedical Inc | -- |
| Harrow Inc | -4.738M |
| Akebia Therapeutics Inc | -19.43M |
| 89bio Inc | -39.72M |
| Humacyte Inc | -27.74M |